Levocarnitine
Back to searchMolecule Structure
Scientific Name
Levocarnitine
Description of the Drug
Levocarnitine is a quaternary ammonium compound used to treat carnitine deficiency or to stimulate gastric and pancreatic secretions in hyperlipoproteinemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00583
http://www.drugbank.ca/drugs/DB00583
Brand Name(s)
Bicarnesine, Biocarn, Carnitor, Carnitor sf, Levocarnitine, Vitamin Bt
Company Owner(s)
Saptalis Pharmaceuticals Llc, American Regent Inc, Lyne Laboratories Inc, Teva Pharmaceuticals Usa, Leadiant Biosciences Inc, Hikma Pharmaceuticals Usa Inc, Novitium Pharma Llc, Akorn Operating Co Llc, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL21970 | |
PharmGKB | PA450154 | |
Human Metabolome Database | HMDB0000062 | |
DrugBank | DB00583 | |
PubChem: Thomson Pharma | 15120307 | 15171033 |
PubChem | 10917 | |
NMRShiftDB | 60020414 | |
BindingDB | 50037268 | |
EPA CompTox Dashboard | DTXSID4023208 | |
DrugCentral | 513 | |
Metabolights | MTBLC16347 | |
Rhea | 16347 | |
ChemicalBook | CB4464378 | |
Guide to Pharmacology | 4780 | |
rxnorm | LEVOCARNITINE | CARNITOR |
KEGG Ligand | C00318 | |
ChEBI | 16347 |